Miniatura

Fitxers

873649.pdf (3.13 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2022-08-16

Llicència de publicació

cc-by (c) Ramos-Muntada, M. et al., 2022
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/218548

Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1002/1878-0261.13276

Resum

B-cell acute lymphoblastic leukemia (B-ALL) is the commonest childhood cancer. High hyperdiploidy (HHD) identifies the most frequent cytogenetic subgroup in childhood B-ALL. Although hyperdiploidy represents an important prognostic factor in childhood B-ALL, the specific chromosome gains with prognostic value in HHD-B-ALL remain controversial, and the current knowledge about the hierarchy of chromosome gains, clonal heterogeneity and chromosomal instability in HHD-B-ALL remains very limited. We applied automated sequential-iFISH coupled with single-cell computational modeling to identify the specific chromosomal gains of the eight typically gained chromosomes in a large cohort of 72 primary diagnostic (DX, n = 62) and matched relapse (REL, n = 10) samples from HHD-B-ALL patients with either favorable or unfavorable clinical outcome in order to characterize the clonal heterogeneity, specific chromosome gains and clonal evolution. Our data show a high degree of clonal heterogeneity and a hierarchical order of chromosome gains in DX samples of HHD-B-ALL. The rates of specific chromosome gains and clonal heterogeneity found in DX samples differ between HHD-B-ALL patients with favorable or unfavorable clinical outcome. In fact, our comprehensive analyses at DX using a computationally defined risk predictor revealed low levels of trisomies +18+10 and low levels of clonal heterogeneity as robust relapse risk factors in minimal residual disease (MRD)-negative childhood HHD-B-ALL patients: relapse-free survival beyond 5 years: 22.1% versus 87.9%, P < 0.0001 and 33.3% versus 80%, P < 0.0001, respectively. Moreover, longitudinal analysis of matched DX-REL HHD-B-ALL samples revealed distinct patterns of clonal evolution at relapse. Our study offers a reliable prognostic sub-stratification of pediatric MRD-negative HHD-B-ALL patients.

Matèries

Anomalies cromosòmiques, Infants, Factors de risc en les malalties, Leucèmia

Matèries (anglès)

Chromosome abnormalities, Children, Risk factors in diseases, Leukemia

Citació

Col·leccions

Articles publicats en revistes (Ciències Fisiològiques)

Citació

RAMOS-MUNTADA, Mireia, TRINCADO, Juan l.., BLANCO, J. (joan), BUENO, Clara, RODRÍGUEZ CORTEZ, Virginia carolina, BATALLER TORRALBA, Alex, LOPEZ MILLAN, Maria belén, SCHWAB, Claire, ORTEGA BLANCO, Margarita, VELASCO, Pablo, BLANCO, Maria l., NOMDEDÉU GUINOT, Josep francesc, RAMÍREZ-ORELLANA, Manuel, MINGUELA, Alfredo, FUSTER, José luis, CUATRECASAS, Esther, CAMÓS GUIJOSA, Mireia, BALLERINI, Paola, ESCHERICH, Gabriele, BOER, Judith m., DEN BOER, Monique l., HERNÁNDEZ-RIVAS, Jesús maría, CALASANZ, María josé, CAZZANIGA, Giovanni, HARRISON, Christine j., MENÉNDEZ, Pablo, MOLINA, Òscar. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia. _Molecular Oncology_. 2022. Vol. 16, núm. 16, pàgs. 2899-2919. [consulta: 26 de gener de 2026]. ISSN: 1574-7891. [Disponible a: https://hdl.handle.net/2445/218548]

Exportar metadades

JSON - METS

Compartir registre